Share

Prevention and Early Detection

ACS CAN advocates for public policies that can prevent nearly half of all cancer deaths by ensuring access to recommended cancer screenings, protecting the public from skin cancer risk, reducing tobacco use and exposure to secondhand smoke and supporting people in increasing physical activity, eating a healthy diet, and managing their weight.

Prevention and Early Detection Resources:

La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) insta al Congreso a financiar el Programa de Control del Cáncer Colorrectal (CRCCP) de los Centros para el Control y la Prevención de Enfermedades (CDC) con $51 millones de dólares en el año fiscal 2027.

La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) insta al Congreso a aumentar el financiamiento para programas contra el cáncer de los Centros para el Control y la Prevención de Enfermedades (CDC) a un mínimo de $482.9 millones de dólares en el año fiscal 2027

La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) insta al Congreso a financiar el Programa Nacional de Registros de Cáncer (NPCR) de los Centros para el Control y la Prevención de Enfermedades (CDC) con $63.4 millones de dólares en el año fiscal 2027.

Llamado a la acción: La Red de Acción contra el Cáncer de la Sociedad Americana contra el Cáncer (ACS CAN) insta al Congreso a respaldar un financiamiento sostenido de $310 millones USD

Access to lifesaving preventive services, including cancer screening, relies on federal preventive care recommendations and guidelines that determine which screenings, tests, and services health insurance plans must cover without cost sharing, including who is eligible, the age at which services

The American Cancer Society Cancer Action Network (ACS CAN) urges Congress to increase funding for the Centers for Disease Control and Prevention’s (CDC) cancer programs to at least $482.9 million in Fiscal Year 2027.

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to fund the Centers for Disease Control and Prevention’s (CDC) National Program for Cancer Registries (NPCR) at $63.4 million in FY 2027. Established by Congress in 1992, the National Program for Cancer Registries suppo

In a letter to Interview magazine Editor and Chief Mel Ottenberg, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong dis

In a letter to Vanity Fair Global Editorial Director Mark Guiducci, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong disappoint

Tobacco Control Resources:

The Family Smoking Prevention and Tobacco Control Act (TCA) requires manufacturers of all new tobacco products to submit an application to the Food and Drug Administration’s Center for Tobacco Products (CTP) for premarket review to prove that the sale of their product is “appropriate for the protection of public health” prior to going on to the market. This is one of the most important provisions of the TCA, and was intended to prevent new, harmful tobacco products from ever being sold. Unfortunately, the premarket review of all new tobacco products has never taken full effect due to lack of enforcement by the agency, the tobacco industry continuing to sell new products without CTP authorization and implementation disruptions.

The Family Smoking Prevention and Tobacco Control Act (TCA) prohibits tobacco manufacturers from using misleading descriptors about their products and requires a substantive scientific review by the Food and Drug Administration's Center for Tobacco Products prior to using any "modified risk" claim. This is one of the most important provisions of the TCA as it directly addresses the tobacco industry's deceptive marketing practices about the harm of its products.

Tobacco use remains the leading cause of preventable death in the United States. No tobacco use is safe or without risk. Commerical tobacco product use, in any form, exposes the body to a myriad of dangerous chemicals and potential health risks.

Quitting tobacco can be challenging. However, a range of FDA-approved services are available to support individuals throughout this process.

New research from ACS CAN finds Big Tobacco’s marketing playbook is going viral on social media. The #Toxic Smoking Aesthetic 2026 report draws on an analysis of hundreds of cigarette-related posts on TikTok and Instagram and identifies five recurring themes – nostalgia, glamour, community, humor, and girlhood – revealing how social media is helping normalize smoking and threatening decades of progress in tobacco prevention.

The American Cancer Society Cancer Action Network (ACS CAN) supports a comprehensive approach to tobacco control that includes significantly increasing excise taxes on all tobacco products to generate revenue, protect kids, and save lives. Significant tobacco tax increases are one of the most effective ways to prevent kids from starting to use tobacco and help adults quit.

 

Llamado a la acción: La Red de Acción contra el Cáncer de la Sociedad Americana contra el Cáncer (ACS CAN) insta al Congreso a respaldar un financiamiento sostenido de $310 millones USD

In a letter to Interview magazine Editor and Chief Mel Ottenberg, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong dis

In a letter to Vanity Fair Global Editorial Director Mark Guiducci, the American Cancer Society Cancer Action Network (ACS CAN), alongside the American Heart Association, American Lung Association, Campaign for Tobacco-Free Kids, Truth Initiative, and Vital Strategies, expressed strong disappoint

Screening Resources:

Breast cancer is the most common cancer diagnosed in women in the U.S. Although there has been substantial progress in reducing breast cancer mortality in the US over the past several decades, there are persistent disparities, especially among Black women. Additionally, breast cancer incidence is increasing, with the steepest trends among young women under 50. In 2025, an estimated 316,950 women in the U.S. will be diagnosed with invasive breast cancer with an additional 59,080 cases of ductal carcinoma in situ (DCIS) in women, and 42,680 will die from the disease. 

ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2025 to accelerate progress in reducing mortality from lung cancer. 

In 2024, an estimated 13,820 people in the U.S. will be diagnosed with invasive cervical cancer, and 4,360 will die from the disease. Cervical cancer can affect any person with a cervix and most often is caused by certain types of human papillomavirus (HPV). Persistent HPV infection causes almost all cervical cancers but fortunately there is a safe and effective vaccine against HPV.

Our latest survey finds that cancer patients and survivors would be less likely to stay current with preventive care, including recommended cancer screenings, if the provision requiring these services be covered at no cost were repealed. This survey also explores the challenges of limited provider networks and the need for patient navigation.

  •